(Q40846409)

24 September 2017

Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment (English)

1 reference

24 September 2017

1 reference

González-Gay MA

1

1 reference

24 September 2017

Blanco R

2

1 reference

24 September 2017

Rodríguez-Valverde V

3

1 reference

24 September 2017

Martínez-Taboada VM

4

1 reference

24 September 2017

Delgado-Rodriguez M

5

1 reference

24 September 2017

Figueroa M

6

1 reference

24 September 2017

Uriarte E

7

1 reference

24 September 2017

language of work or name

1 reference

1 August 1998

1 reference

24 September 2017

Arthritis & Rheumatology

1 reference

24 September 2017

41

1 reference

24 September 2017

1497-1504

1 reference

24 September 2017

8

1 reference

Neurologic disease in biopsy-proven giant cell (temporal) arteritis

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

Polymyalgia rheumatica: a 10-year epidemiologic and clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

Disease patterns and tissue cytokine profiles in giant cell arteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28199808%2941%3A8%3C1497%3A%3AAID-ART22%3E3.0.CO%3B2-Z

10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference